NCT04893252 2022-11-30Vactosertib and Durvalumab in Gastric CancerNational Cancer Center, KoreaPhase 2 Unknown55 enrolled
NCT04656002 2022-06-15As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to BiomarkersSamsung Medical CenterPhase 2 Unknown43 enrolled